SAD |
Biological agent |
Cause of death |
|---|---|---|
Systemic sclerosis |
ADALIMUMAB |
Interstitial pneumonitis |
Still |
ETANERCEPT |
Cardiac failure |
Wegener |
ETANERCEPT |
Colangioc (1), sepsis (1), cardiac arrest (2) |
Behcet |
INFLIXIMAB |
Death by extensive Budd-Chiari (3w after INF) |
DM |
INFLIXIMAB |
Multibacterial aspiration neumonia |
Systemic sclerosis |
INFLIXIMAB |
Peritoneal candidiasis |
MPA +WG |
INFLIXIMAB |
Lung hemorrhage (1), pneumonia post-CFM (1) |
Policondritis |
INFLIXIMAB |
Sepsis MRSA |
Polimiositis |
INFLIXIMAB |
Mycobacteria infection |
Sarcoidosis |
INFLIXIMAB |
TBC |
Sarcoidosis |
INFLIXIMAB |
Abdominal bleeding (mesenteric artery disection) |
Cryoglobulinemia |
RITUXIMAB |
Meningoenceph criptococ |
Cryoglobulinemia |
RITUXIMAB |
Catastophic multisystemic vasculitis |
DM |
RITUXIMAB |
Metastatsic cancer |
Systemic sclerosis |
RITUXIMAB |
Sepsis |
SLE |
RITUXIMAB |
2 (due to chonic disease) |
SLE |
RITUXIMAB |
Lupic pancarditis |
SLE |
RITUXIMAB |
LMP |
CAPS |
RITUXIMAB |
CAPS |